Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

Reports Q3 revenue C$74.8M vs. C$78.5M last year. “Canopy Growth’s (CGC) third quarter highlights that our business has the right ingredients ...

Canopy Growth (CGC) stock drops 15% in premarket after the company posted wider Q3 loss due to revenue and gross margin declines. Read more here.

Be cautious ahead of Canopy Growth Corporation's FQ3 results, as weak financials and low margins may hinder stock performance ...

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announces its financial results ...

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $1.79 per share a year ago. These ...

Canopy Growth Corp. reported a loss of $121.9 million in its latest quarter compared with a loss of $216.8 million in the ...

Canopy Growth Corporation股票所在的制药行业中，整体涨幅为0.91%。其相关个股中，Quantum Biopharma Ltd.、坎伯兰药业、Incannex Healthcare Inc.涨幅较大，Quantum Biopharma Ltd.、坎伯兰药业、大自然药业较为活跃，换手率分别为3178.15%、82.10%、18.45%，振幅较大的相关个股有Quantum ...

The Smiths Falls, Ontario-based cannabis company posted a narrowed net loss of 121.9 million Canadian dollars ($85.2 million), or C$1.11 a share, for the three months ended Dec. 31, compared with a ...

北京时间2025年02月01日02时59分，Canopy Growth Corporation（CGC.us）股票出现波动，股价快速下挫5.24%。截至发稿，该股报1.99美元/股，成交量313.1万股， 换手率 2.56%，振幅6.19%。

Canopy Growth Corporation’s CGC share price has surged by 22.22%, which has investors questioning if this is right time to sell.